OK Biotech Co Ltd
TWSE:4155

Watchlist Manager
OK Biotech Co Ltd Logo
OK Biotech Co Ltd
TWSE:4155
Watchlist
Price: 19.55 TWD -1.01%
Market Cap: 2.9B TWD
Have any thoughts about
OK Biotech Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one OK Biotech Co Ltd stock under the Base Case scenario is 15.29 TWD. Compared to the current market price of 19.55 TWD, OK Biotech Co Ltd is Overvalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
15.29 TWD
Overvaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.1
P/S
P/S
Price to Sales
2.1
vs History
30
vs Industry
39
Median 3Y
2.5
Median 5Y
1.7
Industry
2.3
More Details
59.6
P/E
P/E
Price to Earnings
59.6
vs History
22
vs Industry
2
Median 3Y
51.3
Median 5Y
26.1
Industry
23
More Details
16.1
P/OCF
P/OCF
Price to OCF
16.1
vs History
71
vs Industry
1
Median 3Y
21.1
Median 5Y
23.6
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
5.4
Industry
20
More Details
1.2
P/B
P/B
Price to Book Value
1.2
vs History
53
vs Industry
50
Median 3Y
1.4
Median 5Y
1.4
Industry
2.2
More Details
2.1
EV/S
EV/S
Enterprise Value to Sales
2.1
vs History
26
vs Industry
37
Median 3Y
2.4
Median 5Y
1.7
Industry
2.4
More Details
14.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
14.7
vs History
19
vs Industry
8
Median 3Y
13.6
Median 5Y
9.3
Industry
5
More Details
35.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
35.6
vs History
19
vs Industry
2
Median 3Y
32.2
Median 5Y
19.2
Industry
12.9
More Details
354.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
354.6
vs History
7
vs Industry
1
Median 3Y
83.5
Median 5Y
31.4
Industry
17.4
More Details
16
EV/OCF
EV/OCF
Enterprise Value to OCF
16
vs History
73
vs Industry
1
Median 3Y
20.7
Median 5Y
22.1
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-31.2
Median 5Y
-31.2
Industry
18.2
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
49
vs Industry
48
Median 3Y
1.3
Median 5Y
1.2
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
OK Biotech Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TW
OK Biotech Co Ltd
TWSE:4155
2.9B TWD 2.1 59.6 35.6 354.6
JP
Hoya Corp
TSE:7741
7T JPY 8.5 35.6 23.5 28.3
CH
Alcon AG
SIX:ALC
37.9B CHF 4.3 35.8 17.6 34
DK
Coloplast A/S
CSE:COLO B
178.7B DKK 6.6 35.4 22.8 26.8
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD 4.1 36.4 18.4 22.1
KR
HLB Inc
KOSDAQ:028300
10.3T KRW 199.1 -55.7 -85.7 -80.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
49B CNY 11.1 26.5 23 23
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.6 12
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.7 56
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.3 263.5 460.3
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.6 23.7 38.9
P/E Multiple
Earnings Growth PEG
TW
OK Biotech Co Ltd
TWSE:4155
Average P/E: 36.6
59.6
N/A N/A
JP
Hoya Corp
TSE:7741
35.6
15%
2.4
CH
Alcon AG
SIX:ALC
35.8
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.4
15%
2.4
US
Align Technology Inc
NASDAQ:ALGN
36.4
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -55.7 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.5
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.3
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.3 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.3
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.6
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TW
OK Biotech Co Ltd
TWSE:4155
Average EV/EBITDA: 45.5
35.6
N/A N/A
JP
Hoya Corp
TSE:7741
23.5
15%
1.6
CH
Alcon AG
SIX:ALC
17.6
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.8
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.4
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -85.7 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.6
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
263.5
12%
22
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.7
22%
1.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.